CHIVD CHEMCLIN DIAGNOSTICS CORPORATION
DEAD

Serial Number

88044603

Owner

CHEMCLIN DIAGNOSTICS CO., LTD.

Attorney

Charles Ho

Filing Date

Jul 19, 2018

Add to watchlist:

No watchlists yet
View on USPTO

CHIVD CHEMCLIN DIAGNOSTICS CORPORATION Trademark

Serial Number: 88044603 • Registration: 5882047

CHIVD CHEMCLIN DIAGNOSTICS CORPORATION is a trademark filed by CHEMCLIN DIAGNOSTICS CO., LTD. on July 19, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

CHEMCLIN DIAGNOSTICS CO., LTD. (2 trademarks)

7 FENGXIAN M. RD., YONGFENG BASE,
BEIJING 100094 , CN

Entity Type: 99

BEIJING CHEMCLIN BIOTECH CO., LTD

7 FENGXIAN M. RD.
BEIJING 100094 , CN

Entity Type: 99

Trademark Details

Filing Date

July 19, 2018

Registration Date

October 15, 2019

Published for Opposition

July 30, 2019

Cancellation Date

May 1, 2026

Goods & Services

Pharmaceutical preparations for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; biological preparations for medical purposes for the treatment of thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; chemical preparations for pharmaceutical purposes, namely, for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; chemical preparations for medical purposes, namely, for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; biochemical drug for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; chemical preparations for the diagnosis of pregnancy; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; enzyme preparations for medical purposes; Reagent paper, for medical or veterinary purposes

Surgical apparatus and instruments; medical apparatus and instruments for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; physical exercise apparatus, for medical purposes; apparatus for use in medical analysis for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; testing apparatus for medical purposes for testing thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; diagnostic apparatus for medical purposes for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; sterilization units for medical devices; lasers for medical purposes; isotope apparatus and instruments for diagnosis and treatment, namely, chemiluminescent immunoassay; ultraviolet germicidal lamps for medical use

Filing History

CANCELLED SEC. 8 (6-YR)
May 1, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 15, 2024 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 13, 2019 ASGN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 5, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 5, 2019 REAP
REGISTERED-PRINCIPAL REGISTER
Oct 15, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 30, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jul 30, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 10, 2019 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 26, 2019 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 25, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 25, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 25, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 25, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 25, 2019 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 25, 2019 ZZZX
WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST
Jun 24, 2019 PBER
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 18, 2019 PREV
ASSIGNED TO LIE
Jun 17, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 30, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 29, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2018 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2018 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2018 CNRT
ASSIGNED TO EXAMINER
Nov 6, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 25, 2018 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 24, 2018 NWOS
NEW APPLICATION ENTERED
Jul 23, 2018 NWAP